Bertrand Routy

22PUBLICATIONS
127CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 08, 2026
Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy.

|Jun 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

|Jan 28, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.

Sreya Duttagupta, Meriem Messaoudene, Sebastian Hunter

|Nov 21, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.

Anaïs Perrichet, Julie Lecuelle, Emeric Limagne

|Jul 04, 2025
Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer.

Léa Montégut, Adrien Rousseau, Cinzia Ungolo

|Jun 02, 2025
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development.

Arielle Elkrief, Reilly Pidgeon, Saman Maleki Vareki

Pageof 4

Frequent Collaborators

7 joint publications

Laurence Zitvogel

6 joint publications

Guido Kroemer

6 joint publications

Marine Fidelle

6 joint publications

Lisa Derosa